TP
Teresa Poggio
University Medical Center Freiburg, University of Turin, University of Freiburg, Boston Children's Hospital
Research areas: Medicine · Pathology and Forensic Medicine · Lymphoma Diagnosis and Treatment · Lung Cancer Treatments and Mutations · Cancer Cells and Metastasis
0000-0003-2560-8488
Employment
-
Universitätsklinikum Freiburg PhD student2016 - Present
-
Università degli Studi di Torino Research Fellow2014 - 2016
-
Department of Patology/ MD Roberto Chiarle Research Fellow2014 - 2014
Education
- 2016 - Present
Projects & Funding
-
ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer H2020 Marie Skłodowska-Curie Actions
Publications (13)
- Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model Save
- Loss of the Fanconi anemia–associated protein NIPA causes bone marrow failure Save
- A novel conditional NPM-ALK-driven model of CD30+ T-cell lymphoma mediated by a translational stop cassette Save
- NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia Save
- Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma. Save
- Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas Save
- Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms. Save
- Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells. Save
- Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency. Save
- Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1. Save
- Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors. Save
- ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis. Save
- Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts. Save